Technical Directors:

Reza Saleki
PhD, FACMGG

David Corwin
M.D.

Obstetrics and gynecology cover a broad range of health needs. Women’s Health is a fundamental focus of PAML and we are committed to excellence in women’s healthcare and the required testing to support it. Specialty areas include asymptomatic and symptomatic sexual health, prenatal testing, and oncology. Through testing done in-house or through our Symbiodx joint venture with CellNetix, we can support the continuum of care needed for women’s health practitioners.
 


 

What's New?

SelectSwab Testing

 


 

What You Should Know About STIs
 

Did you know?
For the first time since 2006, the incidence of both chlamydia and gonorrhea are on the rise in the U.S., something the CDC has called a “severe human and economic burden.”1,2 Because chlamydia and gonorrhea are commonly asymptomatic, screening is an essential tool to detect these sexually transmitted infections (STIs) so patients receive much-needed treatment. Trichomoniasis is another STI that takes a widespread toll on patients. Each year, 10 million women visit their healthcare providers seeking a cure for vaginitis.3 Trichomoniasis is one common cause of vaginitis, and it is the most prevalent nonviral STI.2 Regular screening is not recommended for trichomoniasis – testing is recommended instead based on symptoms or patients’ level of risk.4 To help detect trichomoniasis, the CDC recommends testing with nucleic acid amplified technology (NAAT).5
 
Who should be screened?
The decision to test for STIs should be made between a patient and his or her healthcare provider.

Below are some general CDC recommendations for common STIs5:
  • Annual chlamydia and gonorrhea screening for sexually active women age younger than 25.
  • Annual chlamydia and gonorrhea screening for women with increased risk who are 25 and older.
  • Chlamydia and gonorrhea screening for all pregnant women during their first trimester.
  • Annual screening for chlamydia and gonorrhea for men who have sex with men.
  • Trichomoniasis testing considered for women with vaginal discharge or those in high-risk populations.

We proudly offer the Aptima® Combo 2 assay for chlamydia and gonorrhea and the Aptima® Trichomonas vaginalis assay for trichomoniasis detection. These tests offer the high sensitivity and specificity you can count on to be confident in both positive and negative results.

 

Source: ©2016 Hologic MISC-0318-001-CM Rev. 001 “Know Together” brochure. References: 1. Reported Cases of Sexually Transmitted Diseases on the Rise, Some at Alarming Rate [press release]. http://www.cdc.gov/nchhstp/newsroom/2015/std-surveillance-report-press-release. html. Atlanta, GA: CDC; November 17, 2015. 2. CDC. Incidence, Prevalence, and Cost of Sexually Transmitted Infections in the United States. http://www.cdc.gov/std/stats/STI-Estimates-Fact-Sheet-Feb-2013. pdf. Published February 2013. Accessed March 4, 2016. 3. Kent H. Epidemiology of vaginitis. Am J Obstet Gynecol. 1991;165(4):1168-76. doi:10.1016/S0002-9378(12)90722-X. 4. CDC. Trichomoniasis. http://www.cdc.gov/std/tg2015/trichomoniasis.htm. Updated June 4, 2015. Accessed March 4, 2016. 5. CDC. Screening Recommendations Referenced in Treatment Guidelines and Original Recommendation Sources. http://www.cdc.gov/std/tg2015/screeningrecommendations.htm. Updated June 4, 2015. Accessed March 4, 2016.